Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, Maryland; the Obstetrics and Gynecology Institute, Cleveland Clinic Foundation, Cleveland, Ohio; and the Department of Obstetrics and Gynecology, Sidney Kimmel Medical College, Thomas Jefferson University School of Medicine, Philadelphia, Pennsylvania.
Obstet Gynecol. 2024 Apr 1;143(4):491-498. doi: 10.1097/AOG.0000000000005529. Epub 2024 Feb 13.
Molecular diagnostic testing (eg, polymerase chain reaction [PCR]-based vaginitis testing) is widely used in clinical practice, although vaginitis experts have reservations about its use for vaginitis diagnosis. As with any new technology, cost to the health system is a large concern. Although clinical evaluation of signs and symptoms along with wet mount microscopy is traditionally used for vaginitis diagnosis, it is less accurate compared with molecular diagnostic testing. Here we review the benefits of adopting newer molecular diagnostics into routine gynecologic practice with some guidance from vaginitis experts that favor both traditional and more modern approaches. We argue that instead of trying to resist the oncoming tide of molecular diagnostics, we can embrace them and put them to appropriate use to effect rapid, accurate, and more flexible diagnosis of vaginitis conditions for our patients.
分子诊断检测(例如基于聚合酶链反应 [PCR] 的阴道炎检测)在临床实践中得到广泛应用,尽管阴道炎专家对其用于阴道炎诊断持有保留意见。与任何新技术一样,对卫生系统的成本是一个主要关注点。尽管传统上使用体征和症状的临床评估以及湿片显微镜检查来诊断阴道炎,但与分子诊断检测相比,其准确性较低。在这里,我们根据阴道炎专家的建议,回顾了将更新的分子诊断技术纳入常规妇科实践的益处,这些专家赞成传统方法和更现代的方法。我们认为,与其试图抵制分子诊断技术的浪潮,不如接受它们,并将其用于对我们患者的阴道炎状况进行快速、准确和更灵活的诊断。